What is included with this book?
Immune Reactions Towards Biopharmaceuticals - a General, Mechanistic Overview | p. 1 |
Clinical Aspects of Immunogenicity to Biopharmaceuticals | p. 27 |
Assessment of Unwanted Immunogenicity | p. 57 |
Models for Prediction of Immunogenicity | p. 75 |
Immunogenicity of Biopharmaceuticals: Causes, Methods to Reduce Immunogenicity, and Biosimilars | p. 97 |
Case Study: Immunogenicity of rhEPO | p. 113 |
Case Study: Immunogenicity of Interferon-Beta | p. 127 |
Case Study: Immunogenicity of Insulin | p. 137 |
Case Study: Immunogenicity of Factor VIII | p. 147 |
Case Study: Immunogenicity of Natalizumab | p. 173 |
Case Study: Immunogenicity of Anti-TNF Antibodies | p. 189 |
Heparin-Induced Thrombocytopenia | p. 205 |
Presenting an Immunogenicity Risk Assessment to Regulatory Agencies | p. 239 |
Subject Index | p. 259 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.